Markets
Stock market valuation metrics
Careful there (Anadolu/Getty Images)

By any historic metric, this market is getting closer to the edge

The evidence is piling up.

12/4/24 2:45PM

It’s been a great run, the best two-year romp for the S&P 500 since the late 1990s, with a bit of a Santa Claus rally perhaps still to come.

But allow me to be the proverbial fly in the eggnog and note the fact that several of the market’s most time-tested valuation metrics appear to be flashing a giant, red warning signal, complete with sirens.

I know, I know. Valuation is a bit of a quaint concept for today’s investors, who are enjoying gobsmacking gains from electronic crypto doodads and newly minted AI-related behemoths.

But traditionally, the market’s ability to keep climbing is contingent on the earnings that companies are able to generate, the expansion of the economy, and the relative risks and rewards of letting your money ride in the stock market or enjoying safe and steady fixed income on the sidelines. On all those counts, the level of prices on stocks is stretching the limits of traditional stock-market logic.

Earnings

As I’ve said before, the standard forward price-to-earnings multiple of the S&P 500 right now suggests investors are paying a historically high premium for exposure to the market.

But other longer-term iterations of price-to-earnings metrics, like Yale University finance professor Robert Shiller’s Cyclically Adjusted Price-to-Earnings Ratio (CAPE), clearly shows the market is at some of its most expensive levels in history.

For instance, stocks are far more expensive — in terms of their actual earnings over the last decade — than during the bull market of the 1920s, which ended cataclysmically in 1929. The only time on record when they were pricier was during the dot-com boom of the late 1990s, which had a kind of disappointing finale as well.

The economy

Another way to look at the markets is their capitalization as a percentage of the total economy. This yardstick is sometimes known as the Buffett Indicator because of the fact that its one of Warren Buffett’s favorites. It has been going nuts recently, rising into never-before-seen territory, with total capitalization of the stock market — roughly $55 trillion — approximately double the size of the US GDP. (Of course, US companies, especially the multinational megacap tech giants, have seen foreign sales swell as a share of total revenues, so the utility of having the US economy as the denominator has diminished over time.)

In a 2001 piece in Fortune, the Oracle of Omaha said, “If the percentage relationship falls to the 70% or 80% area, buying stocks is likely to work very well for you. If the ratio approaches 200% — as it did in 1999 and a part of 2000 — you are playing with fire.”

No wonder Buffett has been building cash.

Risk-reward trade-offs

All the above warnings signals are derived from the stock market in isolation. But the whole idea of building a portfolio is to weigh your options across asset classes. That’s why looking at the “equity-risk premium” can be helpful.

This chart basically gives you an estimate of how much the market is compensating shareholders for putting their money at risk on the equity-market rollercoaster versus the virtually guaranteed rewards of sticking your cash in government bonds. (Yields there are still high, by the way, with three-month Treasury bills paying almost 4.50%.)

As you can see, you’re getting what’s known on Wall Street by the technical term of bupkis.

So what?

Of course, valuation metrics are famously terrible tools for timing the market. Just because the stocks appear insanely overvalued at the moment, it doesn’t follow that the market is in danger of an imminent collapse.

There are even some reasons why these metrics might be less helpful than they’ve been in the past. For instance, we’ve never had companies in the stock market as big as they currently are in terms of market capitalization. (Apple, Nvidia, and Microsoft are all worth more than $3 trillion.)

That might just reflect the fact that those companies are more powerful players in the economy and thus it makes sense that market capitalization to GDP would be higher than it has been historically.

Likewise, the incoming Trump administration is widely expected to loosen regulatory rules and cut taxes, meaning that the market could be pricing in higher profits than usual going forward. Sure, maybe. But if the market does take a header, or even merely stalls out for a while, don’t be too surprised.

More Markets

See all Markets
markets

Nio surges to an 11-month high following an upgrade from UBS ahead of its new SUV launch

Chinese EV maker Nio is climbing for the fourth straight trading day, following an upgrade from UBS to buy from neutral. Nio’s nearly 7% jump propelled the stock to its highest level since last October.

UBS also bumped its price target for Nio up to $8.50, a 37% hike.

Nio will begin deliveries of its new ES8 SUV this weekend, priced to compete with Tesla’s Model Y. Last week, the EV maker said it planned to raise up to $1 billion on a share offering.

According to UBS analyst Paul Gong, Nio’s latest products “could further attract consumers after the US $1 billion equity offerings strengthened visibility on its healthy operations.”

markets

Moderna is up on the release of positive results for reformulated Covid vaccine

Moderna rose on Tuesday after it announced encouraging trial results for its next Covid-19 vaccine.

The data from its phase 4 clinical trial showed its 2025-2026 formula of its Covid-19 vaccine, which targets a new variant and was recently approved by the FDA with some limitations, produced a strong immune response among people ages 12 through 64. Covid vaccine sales account for virtually all of Moderna's revenue.

The company has had a tumultuous year as the Trump administration makes moves to limit who is able to access the vaccine. Last month, the FDA limited approval for the coronavirus vaccine to higher-risk populations; previously, anyone older than 6 months was eligible for it.

markets

Rivian climbs as it breaks ground on a $5 billion EV plant that could produce 200,000 vehicles a year by 2028

EV tax credits may be ending this month, but Rivian’s still optimistic about future demand.

The electric vehicle maker on Tuesday broke ground on it’s delayed, $5 billion Georgia plant that it says will be able to produce 200,000 vehicles per year by 2028 (Rivian expects to deliver up to 46,000 EVs this year). Its shares climbed more than 6%.

The plant will create 7,500 permanent jobs once complete, according to Rivian, with the first phase of production beginning next year.

2026 also marks the planned launch year for Rivian’s R2 electric SUV, expected to start around $45,000 and compete with Tesla’s Model Y. Earlier this month, Lucid confirmed that it too would be creating a roughly $50,000 electric SUV.

If it seems like an odd time to build an EV plant, it probably is. But unlike larger rivals GM and Honda, Rivian doesn’t have the ability to scale back its EV ambitions — they’re the only vehicles the automaker produces. Last month, the company posted a steeper loss than analysts expected, losing $1.12 billion over its second quarter.

The plant will create 7,500 permanent jobs once complete, according to Rivian, with the first phase of production beginning next year.

2026 also marks the planned launch year for Rivian’s R2 electric SUV, expected to start around $45,000 and compete with Tesla’s Model Y. Earlier this month, Lucid confirmed that it too would be creating a roughly $50,000 electric SUV.

If it seems like an odd time to build an EV plant, it probably is. But unlike larger rivals GM and Honda, Rivian doesn’t have the ability to scale back its EV ambitions — they’re the only vehicles the automaker produces. Last month, the company posted a steeper loss than analysts expected, losing $1.12 billion over its second quarter.

markets

Plug Power jumps on elevated call demand

Plug Power is up today amid a wave of bullish options action.

As of 11:40 a.m. ET, 28,819 calls have traded, nearly double the 20-day average of 14,527.

The two contracts seeing the most activity are calls with a strike price of $2 that expire on October 17 and on this Friday.

The put/call ratio is below 0.13 as of 11:40 a.m., versus a 20-day average of 0.32.

markets

Warner Bros. Discovery dips after TD Cowen downgrade cools deal frenzy

Warner Bros. Discovery shares were down over 8% after TD Cowen downgraded the stock from “buy” to “hold,” even as it kept its $14 price target.

The dip comes on the heels of a sharp rally sparked by reports that Paramount Skydance may bid for the media giant. TD says that while a successful bid could send WBD north of $20, the current risk-reward feels lopsided. If nothing materializes, shares could slip back toward $11 to $12.

Analysts noted that much of the upside from deal chatter is already priced in. TD also flagged limited potential buyers if Paramount Skydance fell though and the lack of concrete details around a bid. In short: the rumor mill has been driving the stock, but fundamentals haven’t clearly caught up.

Reaction has been mixed: last week, Wells Fargo reiterated an equal-weight rating on the stock and hiked its price target to $14 from $13.

Even with today’s dip, WBD shares are still up 67% year to date.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.